The trial, which compared Retevmo to placebo, met its primary endpoint with a “highly statistically significant and clinically meaningful improvement” in investigator-assessed EFS for patients with stage II–IIIA disease
Alto met its enrollment goal with 83 patients across 13 US clinical sites
Ind-Ra expects chronic therapies to outpace IPM as compliance improves and lifestyle diseases rise
PreemieFort Enteral Solution's approval marks the first time a nutritional product derived from human milk has been recognized as a prescription medicine anywhere in the world
The surge has been driven largely by COCO stores, with 755 COCO and 165 FOFO outlets added this fiscal year
The milestone means more than 1,000 men are now enrolled across both Phase 3 programs
Motorica India conducted a specialised masterclass led by Shumaev, centred on real-life rehabilitation scenarios and personalised therapy programs before and after prosthetic fitting
The paper highlights how conditions common across India—including anemia, inherited hemoglobin disorders, and glucose-6-phosphate dehydrogenase (G6PD) deficiency—can significantly distort HbA1c readings
The company’s EBITDA margin remained resilient above 20%
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Stalevo Tablets
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
